Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
140
NCT02285959
Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 30, 2014
Completion: Jun 30, 2025
NCT05905900
Emergent Prep for IV Dye in Acute Stroke Patients With Allergy
Phase: N/A
Start: Jan 1, 2015
Completion: Jun 30, 2023
NCT03347786
Verapamil for Neuroprotection in Stroke
Phase: Phase 1/2
Start: Apr 20, 2017
Completion: Dec 31, 2026